Clinical Trials · NCT00567580

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

UnknownPhase 3Gonadorelin (Unclear)
Phase
Phase 3
Recruitment status
Unknown
Sponsor
Radiation Therapy Oncology Group
Enrollment
1,792
Start date
Feb 2008
Locations
460 sites, 4 countries
Primary endpoint
Percentage of Participants Free From Progression (FFP) at 5 Years
View Gonadorelin compound reference